Phosphodiesterase 3A modulators sensitize tumor cells to Bcl-2/Bcl-xL inhibitors

被引：0
|
作者：
Toivanen, Kirsi L. J.
Murumagi, Astrid
Arjama, Mariliina A.
Merikoski, Nanna J.
Salmikangas, Sami I.
Kallioniemi, Olli P.
Bohling, Tom O.
Sihto, Harri J.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-B028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B028
引用
收藏
页数：2
相关论文
共 50 条
  • [1] In-silico screening of new potential Bcl-2/Bcl-xl inhibitors as apoptosis modulators
    Anna Maria Almerico
    Marco Tutone
    Antonino Lauria
    [J]. Journal of Molecular Modeling, 2009, 15 : 349 - 355
  • [2] In-silico screening of new potential Bcl-2/Bcl-xl inhibitors as apoptosis modulators
    Almerico, Anna Maria
    Tutone, Marco
    Lauria, Antonino
    [J]. JOURNAL OF MOLECULAR MODELING, 2009, 15 (04) : 349 - 355
  • [3] Effects of Bcl-2/Bcl-xL Inhibitors on Pulmonary Artery Smooth Muscle Cells
    Rybka, Vladyslava
    Suzuki, Yuichiro J.
    Shults, Nataliia, V
    [J]. ANTIOXIDANTS, 2018, 7 (11):
  • [4] Towards the next generation of dual Bcl-2/Bcl-xL inhibitors
    Varnes, Jeffrey G.
    Gero, Thomas
    Huang, Shan
    Diebold, R. Bruce
    Ogoe, Claude
    Grover, Paul T.
    Su, Mei
    Mukherjee, Prasenjit
    Saeh, Jamal Carlos
    MacIntyre, Terry
    Repik, Galina
    Dillman, Keith
    Byth, Kate
    Russell, Daniel John
    Ioannidis, Stephanos
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (14) : 3026 - 3033
  • [5] Studies leading to potent, dual inhibitors of bcl-2 and Bcl-xL
    Bruncko, Milan
    Oost, Thorsten K.
    Belli, Barbara A.
    Ding, Hong
    Joseph, Mary K.
    Kunzer, Aaron
    Martineau, Darlene
    McClellan, William J.
    Mitten, Michael
    ng, Shi-Chu Ng
    Nimmer, Paul M.
    Oltersdorf, Tilman
    Park, Cheol-Min
    Petros, Andrew M.
    Shoemaker, Alexander R.
    Song, Xiaohong
    Wang, Xilu
    Wendt, Michael D.
    Zhang, Haichao
    Fesik, Stephen W.
    Rosenberg, Saul H.
    Elmore, Steven W.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (04) : 641 - 662
  • [6] Scalable asymmetric synthesis of a key fragment of Bcl-2/Bcl-xL inhibitors
    Laclef, Sylvain
    Taillier, Catherine
    Penloup, Christine
    Viger, Aurelie
    Briere, Jean-Francois
    Hardouin, Christophe
    Levacher, Vincent
    [J]. RSC ADVANCES, 2014, 4 (75) : 39817 - 39821
  • [7] Bcl-2 and Bcl-xL Suppress Glucose Signaling in Pancreatic β-Cells
    Luciani, Dan S.
    White, Sarah A.
    Widenmaier, Scott B.
    Saran, Varun V.
    Taghizadeh, Farnaz
    Hu, Xiaoke
    Allard, Michael F.
    Johnson, James D.
    [J]. DIABETES, 2013, 62 (01) : 170 - 182
  • [8] Structure-Guided Development of Potent Benzoylurea Inhibitors of BCL-XL and BCL-2
    Roy, Michael J.
    Vom, Amelia
    Okamoto, Toru
    Smith, Brian J.
    Birkinshaw, Richard W.
    Yang, Hong
    Abdo, Houda
    White, Christine A.
    Segal, David
    Huang, David C. S.
    Baell, Jonathan B.
    Colman, Peter M.
    Czabotar, Peter E.
    Lessene, Guillaume
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (09) : 5447 - 5469
  • [9] Effective Targeting of Melanoma Cells by Combination of Mcl-1 and Bcl-2/Bcl-xL/Bcl-w Inhibitors
    Peng, Zhe
    Gillissen, Bernhard
    Richter, Antje
    Sinnberg, Tobias
    Schlaak, Max S.
    Eberle, Juergen
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [10] Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy
    Westhoff, Mike-Andrew
    Schuler-Ortoli, Marie
    Zerrinius, Daniela
    Hadzalic, Amina
    Schuster, Andrea
    Strobel, Hannah
    Scheuerle, Angelika
    Wong, Tiana
    Wirtz, Christian Rainer
    Debatin, Klaus-Michael
    Peraud, Aurelia
    [J]. PHARMACEUTICALS, 2022, 15 (01)
12345